By Turna Ray

NEW YORK (GenomeWeb News) — Although Pathway Genomics announced earlier this week that the US Food and Drug Administration had "classified and registered" its saliva-collection kit as a Class I device, it appears that the company and the agency are not on the same page regarding that designation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.